| 000 | 01526 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517005813.0 | ||
| 264 | 0 | _c20150914 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a1873-2623 | ||
| 024 | 7 |
_a10.1016/j.transproceed.2014.08.045 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFerreiro, A O | |
| 245 | 0 | 0 |
_aEverolimus-based immunosuppression in patients with hepatocellular carcinoma at high risk of recurrence after liver transplantation: a case series. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cDec 2014 |
||
| 300 |
_a3496-501 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAntineoplastic Agents |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
| 650 | 0 | 4 | _aEverolimus |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppression Therapy _xmethods |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aLiver Transplantation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xprevention & control |
| 650 | 0 | 4 |
_aSirolimus _xanalogs & derivatives |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aVazquez-Millán, M A | |
| 700 | 1 | _aLópez, F S | |
| 700 | 1 | _aGutiérrez, M G | |
| 700 | 1 | _aDiaz, S P | |
| 700 | 1 | _aPatiño, M J L | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 46 _gno. 10 _gp. 3496-501 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2014.08.045 _zAvailable from publisher's website |
| 999 |
_c24450421 _d24450421 |
||